BNC Korea Co., Ltd.
256840.KQ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$160.73B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $160.73 Billion |
|---|---|
| Enterprise Value | $99.56 Billion |
| Annual dividend | $70.00 |
| Dividend yield | 2.98% |
| Earnings per Share | $45.41 |
| Beta | 0.5 |
| Outstanding Shares | 68,394,886 |
Return
| Return on Equity | -2.08% |
|---|---|
| Return on Assets | -1.73% |
| Return on Invested Capital | -2.02% |
Valuation & Multiples
| P/E Ratio | -31.77 |
|---|---|
| PEG | 7.29 |
| Price to Sales | 1.71 |
| Price to Book Ratio | 0.67 |
| Enterprise Value to Revenue | 1.09 |
| Enterprise Value to EBIT | -21.02 |
| Enterprise Value to Net Income | -22 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BNC Korea Co., Ltd.
295 employees
CEO: Wan-Gyu Choi
Based in South Korea, BNC Korea Co., Ltd. focuses on the research, development, manufacturing, and distribution of various biomaterials. The company's diverse product range features hyaluronic acid (HA) and skin booster fillers, includin...